ELI LILLY AND COMPANY |
Market Closed -
Other stock markets
|
After market 21:39:02 | |||
| 755.9 USD | -2.68% |
|
754.9 | -0.14% |
| 10:10pm | Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK | MT |
| 02:24pm | Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1 | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
06/05/2024
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
776.8
USD
Average target price
848.3
USD
Spread / Average Target
+9.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.68% | 699B | |
| +25.07% | 571B | |
| -4.35% | 364B | |
| +17.65% | 326B | |
| +3.77% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.79% | 154B | |
| -3.34% | 149B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Insider Trends: Selling By Insiders Lingers at Eli Lilly
